JESFAMI
LIVE

Serial Number

79393685

Owner

Novartis AG

Attorney

Maury M. Tepper, III

Filing Date

Feb 5, 2024

Add to watchlist:

No watchlists yet
View on USPTO

JESFAMI Trademark

Serial Number: 79393685 • Registration: 7830527

JESFAMI is a trademark filed by Novartis AG on February 5, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Novartis AG (12 trademarks)

CH-4002 Basel

Entity Type: 03

Trademark Details

Filing Date

February 5, 2024

Registration Date

June 17, 2025

Published for Opposition

April 29, 2025

Goods & Services

Collection and preservation of human blood; Collection and preservation services for tissue and cells, namely, collection and banking of umbilical cord tissue perivascular stem cells; medical diagnostic services; medical treatment services being medical analysis services relating to the treatment of patients; provision of medical information and remote monitoring of medical data for medical diagnosis and medical treatment

Anti-infectives; Anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; pharmaceutical preparations for the treatment of dermatological diseases; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in the treatment of hematology diseases; pharmaceutical preparations for use in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in the treatment of ophthalmology diseases; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 29, 2026 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jan 14, 2026 FICS
FINAL DISPOSITION PROCESSED
Jan 14, 2026 FIMP
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Oct 3, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 17, 2025 OPNS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 17, 2025 FICR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Sep 17, 2025 OPNR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 17, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 17, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 29, 2025 NPUB
PUBLISHED FOR OPPOSITION
Apr 29, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 23, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 1, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 10, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 10, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 10, 2025 TROA
REFUSAL PROCESSED BY IB
Jan 17, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 2, 2025 RFCS
REFUSAL PROCESSED BY MPU
Jan 2, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 17, 2024 RFCR
NON-FINAL ACTION WRITTEN
Dec 16, 2024 CNRT
ASSIGNED TO EXAMINER
Aug 9, 2024 DOCK
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 13, 2024 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
May 13, 2024 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 13, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 13, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 13, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
May 13, 2024 COAR
APPLICATION FILING RECEIPT MAILED
May 11, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 7, 2024 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
May 2, 2024 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 18, 2024 REPR